156 related articles for article (PubMed ID: 35998093)
1. Population-based study of treatment and outcome of recurrent oesophageal or junctional cancer.
Pape M; Vissers PAJ; Bertwistle D; McDonald L; Beerepoot LV; van Berge Henegouwen MI; Lagarde SM; Mook S; Mohammad NH; Jeene PM; van Laarhoven HWM; Verhoeven RHA
Br J Surg; 2022 Nov; 109(12):1264-1273. PubMed ID: 35998093
[TBL] [Abstract][Full Text] [Related]
2. Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone.
Robb WB; Messager M; Dahan L; Mornex F; Maillard E; D'Journo XB; Triboulet JP; Bedenne L; Seitz JF; Mariette C; ; ; ; ;
Br J Surg; 2016 Jan; 103(1):117-25. PubMed ID: 26511668
[TBL] [Abstract][Full Text] [Related]
3. Recurrence pattern in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer.
van Hagen P; Wijnhoven BP; Nafteux P; Moons J; Haustermans K; De Hertogh G; van Lanschot JJ; Lerut T
Br J Surg; 2013 Jan; 100(2):267-73. PubMed ID: 23180560
[TBL] [Abstract][Full Text] [Related]
4. Pattern of recurrence in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer.
de Jongh M; Eyck BM; van der Werf LR; Toxopeus ELA; van Lanschot JJB; Lagarde SM; van der Gaast A; Nuyttens J; Wijnhoven BPL
BJS Open; 2021 Mar; 5(2):. PubMed ID: 33876211
[TBL] [Abstract][Full Text] [Related]
5. Treatment strategies in recurrent esophageal or junctional cancer.
Butter R; Lagarde SM; van Oijen MGH; Anderegg MCJ; Gisbertz SS; Meijer SL; Hulshof MCCM; Bergman JJGHM; van Berge Henegouwen MI; van Laarhoven HWM
Dis Esophagus; 2017 Sep; 30(9):1-9. PubMed ID: 28859371
[TBL] [Abstract][Full Text] [Related]
6. Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trial.
Panje C; Hayoz S; Eisterer W; Hess V; Thuss-Patience P; Schacher S; Dürr D; Wagner AD; Girschikofsky M; Eboulet E; Stahl M; Ruhstaller T
Eur J Cancer; 2022 Dec; 177():186-193. PubMed ID: 36368252
[TBL] [Abstract][Full Text] [Related]
7. Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.
Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; Muller K; van Laarhoven HW; Hulshof MC
Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27766725
[TBL] [Abstract][Full Text] [Related]
8. Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy.
Dresner SM; Griffin SM
Br J Surg; 2000 Oct; 87(10):1426-33. PubMed ID: 11044172
[TBL] [Abstract][Full Text] [Related]
9. Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer.
de Vos-Geelen J; Geurts SME; Nieuwenhuijzen GAP; Voncken FEM; Bogers JA; Braam PM; Muijs CT; de Jong MA; Kasperts N; Rozema T; Blom GJ; Bouwense SAW; Valkenburg-van Iersel LBJ; Jeene PM; Hoebers FJP; Tjan-Heijnen VCG
Eur J Surg Oncol; 2021 Aug; 47(8):2016-2022. PubMed ID: 33583629
[TBL] [Abstract][Full Text] [Related]
10. Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
Ni W; Yang J; Deng W; Xiao Z; Zhou Z; Zhang H; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Zhang T; Bi N; Deng L; Wang W
BMC Cancer; 2020 Feb; 20(1):144. PubMed ID: 32087687
[TBL] [Abstract][Full Text] [Related]
11. Management of isolated recurrence after surgery for pancreatic adenocarcinoma.
Kim YI; Song KB; Lee YJ; Park KM; Hwang DW; Lee JH; Shin SH; Kwon JW; Ro JS; Kim SC
Br J Surg; 2019 Jun; 106(7):898-909. PubMed ID: 31162655
[TBL] [Abstract][Full Text] [Related]
12. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
Depypere L; Lerut T; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P; Nafteux P
Dis Esophagus; 2017 Jan; 30(1):1-8. PubMed ID: 27704661
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of prognostic factors in patients with locoregional recurrence of esophageal carcinoma after curative treatment].
Xu YP; Mao WM; Ma SL; Jiang YH; Liu JS; Sun XJ
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):925-8. PubMed ID: 22340103
[TBL] [Abstract][Full Text] [Related]
14. Locoregional Recurrence of Esophageal Cancer Treated with Curative Intent Local Salvage Therapy: A Single Center Experience.
Grou-Boileau F; Tankel J; Nevo Y; Najmeh S; Spicer J; Cools-Lartigue J; Mueller C; Ferri L
J Gastrointest Cancer; 2023 Dec; 54(4):1292-1299. PubMed ID: 36988820
[TBL] [Abstract][Full Text] [Related]
15. Patterns of recurrence after oesophagectomy and postoperative chemoradiotherapy versus surgery alone for oesophageal squamous cell carcinoma.
Hsu PK; Chen HS; Huang CS; Liu CC; Hsieh CC; Hsu HS; Wu YC; Wu SC
Br J Surg; 2017 Jan; 104(1):90-97. PubMed ID: 27859017
[TBL] [Abstract][Full Text] [Related]
16. Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers.
Jestin Hannan C; Linder G; Kung CH; Johansson J; Lindblad M; Hedberg J
Br J Surg; 2020 Oct; 107(11):1500-1509. PubMed ID: 32484241
[TBL] [Abstract][Full Text] [Related]
17. Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma.
Kato H; Miyazaki T; Nakajima M; Fukuchi M; Manda R; Kuwano H
Br J Surg; 2004 Aug; 91(8):1004-9. PubMed ID: 15286962
[TBL] [Abstract][Full Text] [Related]
18. Stage for stage comparison of recurrence patterns after definitive chemoradiotherapy or surgery for oesophageal carcinoma.
Reid TD; Davies IL; Mason J; Roberts SA; Crosby TD; Lewis WG
Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):617-24. PubMed ID: 22386923
[TBL] [Abstract][Full Text] [Related]
19. Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy.
Nagaki Y; Motoyama S; Sato Y; Wakita A; Fujita H; Sasaki Y; Imai K; Minamiya Y
BMC Cancer; 2021 Nov; 21(1):1192. PubMed ID: 34753448
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma.
Chen TH; Pan YY; Lee TL; Wang LW; Tai SK; Chu PY; Lo WL; Wu CH; Yang MH; Chang PM
BMC Cancer; 2022 Dec; 22(1):1336. PubMed ID: 36539738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
